155 related articles for article (PubMed ID: 20371355)
1. Algorithms for the automated selection of fragment-like molecules using single-point surface plasmon resonance measurements.
Kreatsoulas C; Narayan K
Anal Biochem; 2010 Jul; 402(2):179-84. PubMed ID: 20371355
[TBL] [Abstract][Full Text] [Related]
2. From experimental design to validated hits a comprehensive walk-through of fragment lead identification using surface plasmon resonance.
Giannetti AM
Methods Enzymol; 2011; 493():169-218. PubMed ID: 21371592
[TBL] [Abstract][Full Text] [Related]
3. Integrating surface plasmon resonance biosensor-based interaction kinetic analyses into the lead discovery and optimization process.
Danielson UH
Future Med Chem; 2009 Nov; 1(8):1399-414. PubMed ID: 21426056
[TBL] [Abstract][Full Text] [Related]
4. Target immobilization as a strategy for NMR-based fragment screening: comparison of TINS, STD, and SPR for fragment hit identification.
Kobayashi M; Retra K; Figaroa F; Hollander JG; Ab E; Heetebrij RJ; Irth H; Siegal G
J Biomol Screen; 2010 Sep; 15(8):978-89. PubMed ID: 20817886
[TBL] [Abstract][Full Text] [Related]
5. Experiences in fragment-based lead discovery.
Hubbard RE; Murray JB
Methods Enzymol; 2011; 493():509-31. PubMed ID: 21371604
[TBL] [Abstract][Full Text] [Related]
6. Combining biophysical screening and X-ray crystallography for fragment-based drug discovery.
Hennig M; Ruf A; Huber W
Top Curr Chem; 2012; 317():115-43. PubMed ID: 21837555
[TBL] [Abstract][Full Text] [Related]
7. Experimental validation of a fragment library for lead discovery using SPR biosensor technology.
Elinder M; Geitmann M; Gossas T; Källblad P; Winquist J; Nordström H; Hämäläinen M; Danielson UH
J Biomol Screen; 2011 Jan; 16(1):15-25. PubMed ID: 21149860
[TBL] [Abstract][Full Text] [Related]
8. A new strategy for improved secondary screening and lead optimization using high-resolution SPR characterization of compound-target interactions.
Huber W
J Mol Recognit; 2005; 18(4):273-81. PubMed ID: 15997470
[TBL] [Abstract][Full Text] [Related]
9. Looking towards label-free biomolecular interaction analysis in a high-throughput format: a review of new surface plasmon resonance technologies.
Boozer C; Kim G; Cong S; Guan H; Londergan T
Curr Opin Biotechnol; 2006 Aug; 17(4):400-5. PubMed ID: 16837183
[TBL] [Abstract][Full Text] [Related]
10. Emerging role of surface plasmon resonance in fragment-based drug discovery.
Navratilova I; Hopkins AL
Future Med Chem; 2011 Oct; 3(14):1809-20. PubMed ID: 22004086
[TBL] [Abstract][Full Text] [Related]
11. Label-free and time-resolved measurements of cell volume changes by surface plasmon resonance (SPR) spectroscopy.
Robelek R; Wegener J
Biosens Bioelectron; 2010 Jan; 25(5):1221-4. PubMed ID: 19818594
[TBL] [Abstract][Full Text] [Related]
12. Impact of new technologies for cellular screening along the drug value chain.
Möller C; Slack M
Drug Discov Today; 2010 May; 15(9-10):384-90. PubMed ID: 20206290
[TBL] [Abstract][Full Text] [Related]
13. Fragment screening by SPR and advanced application to GPCRs.
Shepherd CA; Hopkins AL; Navratilova I
Prog Biophys Mol Biol; 2014; 116(2-3):113-23. PubMed ID: 25301577
[TBL] [Abstract][Full Text] [Related]
14. Fragment-based screening using surface plasmon resonance technology.
Perspicace S; Banner D; Benz J; Müller F; Schlatter D; Huber W
J Biomol Screen; 2009 Apr; 14(4):337-49. PubMed ID: 19403917
[TBL] [Abstract][Full Text] [Related]
15. Developments in SPR Fragment Screening.
Chavanieu A; Pugnière M
Expert Opin Drug Discov; 2016; 11(5):489-99. PubMed ID: 26948323
[TBL] [Abstract][Full Text] [Related]
16. Novel trends in high-throughput screening.
Mayr LM; Bojanic D
Curr Opin Pharmacol; 2009 Oct; 9(5):580-8. PubMed ID: 19775937
[TBL] [Abstract][Full Text] [Related]
17. Surface plasmon resonance analysis of seven-transmembrane receptors.
Aristotelous T; Hopkins AL; Navratilova I
Methods Enzymol; 2015; 556():499-525. PubMed ID: 25857797
[TBL] [Abstract][Full Text] [Related]
18. A SPR strategy for high-throughput ligand screenings based on synthetic peptides mimicking a selected subdomain of the target protein: a proof of concept on HER2 receptor.
Monfregola L; Vitale RM; Amodeo P; De Luca S
Bioorg Med Chem; 2009 Oct; 17(19):7015-20. PubMed ID: 19733086
[TBL] [Abstract][Full Text] [Related]
19. Determination of the refractive index increments of small molecules for correction of surface plasmon resonance data.
Davis TM; Wilson WD
Anal Biochem; 2000 Sep; 284(2):348-53. PubMed ID: 10964419
[TBL] [Abstract][Full Text] [Related]
20. Guest editor's introduction: Label-free optical biosensors to cell biology and drug discovery. Introduction.
Fang Y
J Recept Signal Transduct Res; 2009; 29(3-4):127. PubMed ID: 19640218
[No Abstract] [Full Text] [Related]
[Next] [New Search]
